Internal Medicine, Endocrinology, Diabetes, & Metabolism · Midlothian, VA
NPI
1831181734
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
348 Brown's Hill Ct
Midlothian, VA, 23114
Phone (804) 272-2702
Groups this clinician bills Medicare through
Medicare paid, 2024
$257K
6,941 services
Medicare patients, 2024
710
Average age 75
Drug cost, 2024
$989K
6,226 prescriptions
Company payments, 2025
$2,099
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meredith M Berger was code J0897 (injection, denosumab, 1 mg), 4,260 times for 44 patients. In total Meredith M Berger billed 6,941 services in 18 codes, and Medicare paid $257K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,260 | 44 | $20.52 | $87K |
| 99214 Office E&M - Established | Office | 1,266 | 656 | $86.22 | $109K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 482 | 388 | $11.71 | $5,646 |
| 99215 Office E&M - Established | Office | 231 | 188 | $125.55 | $29K |
| 82962 Clinical Chemistry | Office | 160 | 93 | $3.19 | $510 |
| 76536 Ultrasound - Nonspecific | Office | 110 | 103 | $80.60 | $8,866 |
| 99213 Office E&M - Established | Office | 109 | 90 | $59.26 | $6,459 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 96 | 96 | $24.41 | $2,343 |
| 96372 Injection Administration | Office | 91 | 46 | $11.05 | $1,005 |
| 95251 Test - Miscellaneous | Office | 58 | 39 | $23.41 | $1,358 |
| 99204 Office E&M - New | Office | 27 | 27 | $87.05 | $2,350 |
| 77080 Standard X-ray | Office | 26 | 26 | $37.19 | $967 |
| 10005 Other Organ Systems | Office | 12 | 11 | $89.66 | $1,076 |
By year: 2022 $222K for 6,085 services; 2023 $245K for 6,318 services; 2024 $257K for 6,941 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 160 | 93 | $3.19 | $510 |
Medicare prescription drug claims, 2024
In 2024, the drug Meredith M Berger prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 890 prescriptions and refills. In total Meredith M Berger wrote 6,226 Medicare prescriptions that cost $989K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 890 | 2,384 | 180 | $59K |
| Levothyroxine Sodium Generic | 808 | 2,321 | 204 | $7,255 |
| Rosuvastatin Calcium Generic | 257 | 744 | 75 | $3,087 |
| Levoxyl Levothyroxine Sodium | 247 | 663 | 57 | $9,986 |
| Metformin Hcl Er Metformin Hcl | 234 | 689 | 74 | $2,659 |
| Glimepiride Generic | 167 | 471 | 52 | $1,996 |
| Atorvastatin Calcium Generic | 149 | 445 | 43 | $1,666 |
| Spironolactone Generic | 123 | 341 | 34 | $1,320 |
| Unithroid Levothyroxine Sodium | 122 | 361 | 34 | $2,514 |
| Losartan Potassium Generic | 108 | 298 | 29 | $860 |
| Hydrochlorothiazide Generic | 107 | 315 | 30 | $536 |
| Amlodipine Besylate Generic | 96 | 285 | 29 | $584 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 92 | 241 | 35 | $23K |
| Alendronate Sodium Generic | 92 | 247 | 28 | $452 |
| Jardiance Empagliflozin | 86 | 180 | 21 | $101K |
Brand drugs: 2,503 claims; generic drugs: 3,600 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meredith M Berger $2,099 ($2,099 in general payments such as food, travel and fees) from 29 companies. The largest payer was Radius Health, Inc. with $232.
| Company | Payments | Amount |
|---|---|---|
| Radius Health, Inc. | 7 | $232 |
| Amgen Inc. AMGN | 13 | $188 |
| Lilly USA, LLC LLY | 9 | $154 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $153 |
| Novo Nordisk Inc NVO | 8 | $144 |
| Xeris Pharmaceuticals, Inc. | 5 | $111 |
| Recordati_rare_diseases_inc. | 5 | $98.61 |
| Sequel Med Tech, LLC | 4 | $96.67 |
| IBSA Pharma Inc. | 4 | $93.46 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $85.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.